Skip to search formSkip to main contentSkip to account menu

Neuronox

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract Introduction Neuronox® has not yet been investigated for its efficacy and safety in the treatment of lateral canthal… 
Review
2018
Review
2018
OBJECTIVE: The objective of this selective EBM review is to determine whether or not botulinum toxin A is an effective treatment… 
2017
2017
Purpose To compare the efficacy and safety of Botox and Neuronox in the management of benign essential blepharospasm (BEB… 
2016
2016
Botulinum toxin blocks the release of the neurotransmitter acetylcholine and helps to treat wrinkles. The efficacy and safety of… 
2015
2015
Background Botulinum toxin type A is widely used for treating spasticity. Neuronox (Neu-BoNT/A), a newly manufactured botulinum… 
2012
2012
Hemifacial spasm (HFS) is a disease causing abnormal movement of the face. Treatment with a botulinum toxin injection is… 
2011
2011
Aim  The aim of this study was to evaluate the efficacy and safety of a newly manufactured botulinum toxin, Neuronox, compared… 
2011
2011
Study design, materials and methods This was an open-label observational study comparing Neuronox® and Botox®(300 IU) in 24… 
2006
2006
ZusammenfassungTherapeutische Präparationen von Botulinum-Toxin (BT) bestehen aus Botulinum-Neurotoxin (BNT), Komplexproteinen…